International
Français Deutsch
Web TV
Investor's reporting Investor's reporting
Online Due Diligence
Venture Capital
Investments

Cytheris

Cytheris (Cytokine Therapy for the Immune System) is a French biotechnology company developing medical treatments aimed at the global reconstitution of the immune system and the improvement of specific immune responses (vaccines) among immuno-depressive subjects. Clinical trials are under way in Europe and the United States.

Cytheris

Development of medicines for the immune system

July-02

Visit other AXA sites:
Site Map Terms and conditions